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Poster Presentations: Wednesday, July 17, 2019S1530neuropsychological test scores in older surgical patients presenting
for elective spine operations. Methods: This was a prospective
cohort study of 52 patients aged 65-89 years, having elective, inpa-
tient spine surgery under general anesthesia. To determine the val-
idity of cognitive screening using the Mini-Cog, we compared
Mini-Cog scores with neuropsychological test scores. Neuropsy-
chological tests included Digit Symbol Substitution to test attention
and concentration, Animal Category Fluency and Trail Making
Tests A & B to test executive function, and CERADWord List De-
layed Recall, Logical Memory Immediate & Delayed Recall to test
Memory. Clinical Dementia Rating (CDR) and Instrumental Activ-
ities of Daily Living (IADL) were also assessed. Results: Of 52 pa-
tients enrolled, 9 patients scored between 0-2 (compatible with
cognitive impairment) on the Mini-Cog, while 43 scored between
3-5. There were significant differences between the two groups in
Digit Symbol Substitution Test scores (p¼0.02), CERAD Word
List Delayed Recall (p¼0.05), Trail Making Test A (p<0.001),
and Trail Making Test B (p<0.01). (See table) Of note, there was
no difference between the two groups Mini-Mental State Examina-
tion scores. The two groups also had significantly different Clinical
Dementia Ratings (p¼0.02) and Instrumental Activities of Daily
Living scores (p<0.01). Conclusions: These data support the valid-
ity of administering the Mini-Cog as a brief screening tool for
cognitive impairment in older patients presenting for elective spine
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Contact e-mail: dotjandr@umich.eduBackground: Electronic health records (EHRs) contain decades of
longitudinal clinical data on hundreds of thousands of potentially
at-risk individuals for Alzheimer’s disease (AD). The ability to
automatically identify probable AD patients within EHRs would
facilitate downstream computational analyses on such large-scale
datasets, by eliminating the need for labor intensive chart review.
To this end, we developed and validated a cohort discovery tool
that can be applied to EHR data for automatic classification of in-
dividuals with AD. Methods: We extracted EHR data from Mich-
igan Medicine’s Research Data Warehouse (RDW) pertaining to
Michigan Alzheimer’s Disease Center (MADC) participants
with a consensus-based diagnosis ranging from cognitively
normal to probable AD. We investigated the accuracy of different
EHR-based rules for identifying patients with AD. Rules were
based on combinations of criteria pertaining to ICD diagnoses,
medications, laboratory results and encounter types. Applied to
data from the RDW, these rules were evaluated against MADC di-
agnoses (Figure 1), in terms of sensitivity, specificity, and positive
predicted value (PPV). To optimize for the probability that pa-
tients identified by the rule have AD, we prioritized PPV when
ranking different rules. Results: MADC and RDW records over-
lapped in 624 patients 65 years and older. Though a diagnostic
code for AD alone resulted in relatively low specificity, combina-
tion with an encounter involving medium/high complexity medi-
cal decision making resulted in increased specificity and the
highest PPV (Figure 2). This rule yielded a PPV, specificity, and
sensitivity of 0.82 (95% confidence interval (CI) 0.75-0.87),
0.95 (95%CI 0.93-0.97), and 0.65 (95%CI 0.60-0.68) respec-
tively. For true positives, the first RDW diagnosis of probable
AD occurred on average three years before the first MADC diag-
nosis (95% CI 2.3-3.7 years). Applied to the entire RDW, this rule
identified 4,152 patients with probable AD. Conclusions: EHR-
based criteria can automatically and accurately identify patients
with probable AD. Applied to large longitudinal EHR datasets,
these labels can be used for downstream analyses, e.g., modeling
patient trajectories of disease progression.
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Contact e-mail: dotjandr@umich.eduBackground: To date, predictive modeling for Alzheimer’s disease
(AD) risk has focused on data not routinely collected in clinical
care and is limited to short prediction horizons (e.g., 2-4 years).
Given the limitations of existing datasets, we sought to leverage
electronic health records (EHRs) that contain decades of longitudi-
nal data for thousands of patients, with the goal of developing and
validating a predictive model for AD onset with a 10-year predic-
tion horizon. Methods: A retrospective study included patients
aged 68-72 admitted to Michigan Medicine prior to 2008 with at
least 10 years of follow-up. To control for age, we aligned patientsbetween 68-72 years. Given EHR data up to and including the visit
of alignment, we sought to predict the primary outcome: probable
AD within the next 10 years (labeled by a previously validated
cohort discovery tool). Patients were repeatedly randomly divided
into a training and test sets. Using EHR-based covariates (e.g., de-
mographics, diagnoses, procedures, vital signs, laboratory results,
medications), we learned a linear model to predict AD. Predictive
performance was measured on held-out test data using area under
the receiver operating characteristics curve (AUROC). Covariates
were ranked according to predictive power, using permutation
importance. Results: After applying inclusion/exclusion criteria
(Figure 1), patients in the final study population (n¼8,416) had a
median of 11 encounters prior to alignment (interquartile range
(IQR)¼4-25) and a median of 84 encounters during follow-up
(IQR¼36-172). The model achieved an AUROC of 0.708
(IQR¼0.686-0.733). Important predictive factors included health-
care utilization, testing for secondary causes of AD, and cardiovas-
cular factors (Figure 2). Identifying at-risk patients more than 6
years in advance was possible, though more difficult (Figure 3).
Conclusions: Using longitudinal EHR data, we can predict AD in
advance of clinical diagnosis with modest accuracy. Mining
routinely collected data could shed light on AD progression, espe-
cially in the decades before clinical onset.
